Merck & Co., (MRK) Financials
Merck & Co., (MRK) Historical Financial Statements and Key Metrics for 1994 - 2023
Full Merck & Co., financials for 1994 - 2023 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Merck & Co., Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2023-Dec-31 | 14,630 | 11,290 (77.2 %) | -299 (-2.0 %) | -1,226 (-8.4 %) | 679 | -0.48 |
| 2023-Sep-30 | 15,962 | 11,698 (73.3 %) | 5,998 (37.6 %) | 4,745 (29.7 %) | 5,998 | 1.86 |
| 2023-Jun-30 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2023-Mar-31 | 14,487 | 10,561 (72.9 %) | 2,882 (19.9 %) | 2,821 (19.5 %) | 3,873 | 1.11 |
| 2022-Dec-31 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2022-Sep-30 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2022-Jun-30 | 14,593 | 10,377 (71.1 %) | 5,067 (34.7 %) | 3,944 (27.0 %) | 5,660 | 1.55 |
Full historical income statements for 1994 - 2023 is included in the
US Historical Financials dataset.
Merck & Co., Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2023-Dec-31 | 106,675 | 69,040 | 36,268 | 37,581 | 7,161 |
| 2023-Sep-30 | 106,727 | 65,427 | 34,859 | 41,246 | 8,773 |
| 2023-Jun-30 | 104,469 | 65,727 | 36,911 | 38,693 | 6,378 |
| 2023-Mar-31 | 107,796 | 60,891 | 30,746 | 46,834 | 10,387 |
| 2022-Dec-31 | 109,160 | 63,102 | 30,691 | 45,991 | 13,192 |
| 2022-Sep-30 | 107,081 | 62,557 | 30,418 | 44,458 | 11,248 |
| 2022-Jun-30 | 107,095 | 63,777 | 31,663 | 43,243 | 10,128 |
Full historical balance sheet data for 1994 - 2023 is included in the
US Historical Financials dataset.
Merck & Co., Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2023-Dec-31 | 246 | 53 | -2,245 | -743 |
| 2023-Sep-30 | 7,717 | -334 | -4,269 | 6,815 |
| 2023-Jun-30 | 3,704 | -11,443 | 3,758 | 2,739 |
| 2023-Mar-31 | 1,339 | -2,359 | -2,054 | 332 |
| 2022-Dec-31 | 4,430 | -1,748 | -1,554 | 3,281 |
| 2022-Sep-30 | 5,602 | -962 | -2,702 | 4,476 |
| 2022-Jun-30 | 4,302 | -1,077 | -1,777 | 3,173 |
Full historical cash flow data for 1994 - 2023 is included in the
US Historical Financials dataset.
Merck & Co., Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2023-Dec-31 | 276,148 | 305,507 | 18.88 | -56.31 | 7.35 |
| 2023-Sep-30 | 261,238 | 287,492 | 16.37 | 13.76 | 6.33 |
| 2023-Jun-30 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2023-Mar-31 | 270,018 | 291,057 | 18.64 | 23.93 | 5.77 |
| 2022-Dec-31 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2022-Sep-30 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2022-Jun-30 | 230,751 | 252,739 | 15.81 | 14.63 | 5.34 |
Full historical valuation and operating metrics for 1994 - 2023 are included in the
US Historical Financials dataset.